3 recruiting, 1 not yet recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 3, Not yet recruiting 1 |
Follow Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma: new trials by email Literature Review of Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma trials Research Report on Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC PD-1 Inhibitor plus Chemotherapy, Oral Enteral Nutritional Preparation, Esophagectomy with lymph node dissection - Esophageal Squamous Cell Carcinoma, Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Recruiting | Sichuan University | 118 | 2026-04-01 | 2026-04-15 |
| Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma oral paclitaxel+radiotherapy - Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Recruiting | Jiangsu Cancer Institute & Hospital | 22 | 2025-12-01 | 2026-02-27 |
| Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma Camrelizumab - Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Recruiting | Ning Jiang, M.D./Ph.D. | 98 | 2025-12-01 | 2026-04-15 |
| A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) Induction stage：Adebrelimab+TC；Treatment stage: TC/PF+ radiation therapy；Maintenance stage: Adebrelimab - Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | Hebei Medical University Fourth Hospital | 36 | 2025-08-10 | 2025-08-08 |
Esophageal Neoplasms (3) · Esophageal Squamous Cell Carcinoma (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Esophageal Diseases (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Head and Neck Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Squamous Cell (1)
130-nm albumin-bound paclitaxel (1) · Carboplatin (1) · Drug Therapy (1) · Esophagectomy (1) · Immune Checkpoint Inhibitors (1) · Lymph Node Excision (1) · camrelizumab (1)
Hebei Medical University Fourth Hospital (1) · Jiangsu Cancer Institute & Hospital (1) · Ning Jiang, M.D./Ph.D. (1) · Sichuan University (1)
China (4)
Xiangzhi Zhu (2) · Zhenyu Ding, PhD (1)